First Trimester Prenatal Screening for Preeclampsia (11-14 weeks)

• Test Name: First Trimester Prenatal Screening for Preeclampsia (11-14 weeks)
• Test Type: Blood test combined with ultrasound
• Specimen Required: Blood sample from the mother and ultrasound measurements
• Methodology: Measures biomarkers in the mother’s blood, including pregnancy-associated plasma protein-A (PAPP-A) and placental growth factor (PlGF), combined with an ultrasound to measure fetal nuchal translucency (NT).
• Purpose: To assess the risk of developing preeclampsia, a condition characterized by high blood pressure and potential damage to organs, particularly during pregnancy.

• Risk Prediction: Predicts the likelihood of a pregnant woman developing preeclampsia later in pregnancy.
• Screening: Part of a broader prenatal screening that also evaluates risks for chromosomal abnormalities such as Down syndrome and trisomy 18.
• Preventive Care: Helps doctors initiate early preventive measures, such as prescribing low-dose aspirin to reduce the risk of preeclampsia.

• Biomarkers: Measurement of specific proteins like PAPP-A and PlGF in maternal blood, which are indicative of placental function and development.
• Ultrasound: A detailed ultrasound to measure fetal nuchal translucency (NT), a marker that may also suggest risk of chromosomal abnormalities.
• Blood Pressure: Blood pressure readings and maternal medical history may be included in the assessment.

• Low Risk: A low level of risk indicates that the chance of developing preeclampsia is minimal, and regular prenatal care can continue.
• High Risk: A high level of risk suggests the potential for preeclampsia, warranting closer monitoring and preventive interventions, such as lifestyle adjustments and medications like aspirin.
• Combined Analysis: Results are often combined with other first-trimester screening results to give a more comprehensive risk assessment for both preeclampsia and chromosomal abnormalities.

• Turnaround Time: Results are usually available within a few days to a week after the test.
• Positive Screening: A positive screening result doesn’t confirm preeclampsia but indicates a higher risk, prompting the need for increased monitoring and possible preventive care.
• Negative Screening: A negative result indicates a low risk for preeclampsia during pregnancy, but routine check-ups should still continue.
• Clinical Follow-up: Women at high risk may be referred for more frequent prenatal visits, specialist consultations, and possible early interventions.

Q. What is the First Trimester Prenatal Screening for Preeclampsia?
It is a screening test done between 11 and 14 weeks of pregnancy to assess the risk of developing preeclampsia later in pregnancy by analyzing maternal blood biomarkers and ultrasound measurements
 

Q. Why is this screening important?
Early detection of the risk for preeclampsia allows healthcare providers to take preventive measures, reducing the likelihood of complications for both the mother and the baby
 

Q. How is the screening performed?
A blood sample is taken to measure specific proteins (PAPP-A and PlGF), and an ultrasound is done to measure the baby's nuchal translucency. These results are combined with maternal health data to estimate preeclampsia risk
 

Q. What happens if my screening result is positive?
A positive result means you are at higher risk of developing preeclampsia. Your healthcare provider may recommend increased monitoring and possibly prescribe low-dose aspirin to lower the risk of the condition
 

Q. What should I do if my screening result is negative?
A negative result indicates a low risk for preeclampsia, but it is important to continue regular prenatal care to monitor for any symptoms or changes throughout the pregnancy
 

Q. Is this test mandatory during pregnancy?
No, this test is not mandatory but is recommended for early risk assessment. It helps provide information that can guide preventive care, especially for women with risk factors for preeclampsia
 

Q. Can this test diagnose preeclampsia?
No, this screening cannot diagnose preeclampsia. It only assesses the risk of developing it. A diagnosis would be made later in pregnancy if symptoms, such as high blood pressure, arise